CONX Corp.: Nasdaq/NYSE listing notice — CONX Corp. receives Nasdaq delisting notice for failure to maintain $35M MVLS

CONX Corp.

On Feb 14, 2024, Nasdaq notified CONX that it failed to regain compliance with minimum MVLS of $35M by Feb 12 deadline.
Company will present views to Nasdaq Hearings Panel by Feb 21, 2024; trading continues pending Panel decision.
Follows prior non-compliance disclosure in Aug 2023; 180-day cure period expired without remedy.
CONX units, Class A common stock, and warrants continue trading on Nasdaq under symbols CONXU, CONX, CONXW.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

CONX Corp. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(2)

Exact text from the filing

sly disclosed on the Current Report on Form 8-K filed by CONX Corp., a Nevada corporation (the “Company”) with the Securities and Exchange Commission on August 18, 2023, on August 14, 2023, the staff of The Nasdaq Stock Market LLC (“Nasdaq”) notified the Company that it no longer meets Listing Rule 5550(b)(2) (the “Rule”) requiring the Company to maintain a minimum market value of listed securities (“MVLS”) of $35 million. The notice was based on a review of the Company’s MVLS for the past 30 consecutive business days. Nasdaq’s listing rules provided the Company a compliance period of 180 cale

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-24-025556

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.